Memory disorders research study
Part of Brain & nervous system, Mental health clinical trials.
This study collects health information and samples from people with memory problems and from healthy younger adults to better understand memory disorders. Participating may help researchers learn more about these conditions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 50 years of age or older
- You do not have an uncontrolled infection or other life-threatening illness
- You are willing to participate and can consent, or a family member can consent if needed
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a computer-based platform to test memory and thinking in healthy adults and in people with mild memory concerns (called aMCI). The goal is to better understand how memory changes with age and to spot early signs of Alzheimer's disease.
This study looks at how “slower movement” and brain changes relate to memory and thinking problems in people with early dementia (and some related conditions). It may help researchers understand what brain differences go with these symptoms, using tests and an MRI scan.
This study looks at memory and thinking changes using questionnaires, memory testing, and brain scans. It may help researchers better understand neurodegeneration and dementia and how these problems show up over time.
This study looks at how memory and thinking skills change in older adults living in the Yuyuan community. By taking part, you'll help researchers learn more about brain health in aging, and you'll have free health check-ups like memory tests and brain scans.
This registry collects information from people with mild cognitive impairment or Alzheimer's disease who are starting a new medication. It helps researchers learn more about these conditions and their treatments over time.
This study looks at blood and imaging markers (biomarkers) to better understand and diagnose dementia and mild cognitive impairment. It aims to improve early detection and may help guide future treatments.
Hear when a new Dementia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.